1. |
Davidson LJ, Davidson CJ. Transcatheter treatment of valvular heart disease: A review. JAMA, 2021, 325(24): 2480-2494.
|
2. |
王春生, 陆树洋. COMMENCE (SAVR) 研究五年随访结果给中国主动脉瓣膜外科带来的思考. 中国胸心血管外科临床杂志, 2021, 28(8): 877-883.
|
3. |
Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of transcatheter aortic valve replacement. J Am Coll Cardiol, 2020, 76(21): 2492-516.
|
4. |
Otto CM, Nishimura RA, Bonow R O, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation, 2021, 143(5): e72-e227.
|
5. |
Shang X, Chen S, Zhang C, et al. First-in-man implantation of Med-Zenith PT-valve in right ventricular outflow tract for pulmonary regurgitation. JACC Cardiovasc Interv, 2019, 12(19): 1989-1990.
|
6. |
Siontis GCM, Overtchouk P, Cahill TJ, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: An updated meta-analysis. Eur Heart J, 2019, 40(38): 3143-3153.
|
7. |
Zhang XL, Zhang XW, Lan RF, et al. Long-term and temporal outcomes of transcatheter versus surgical aortic-valve replacement in severe aortic stenosis: A meta-analysis. Ann Surg, 2021, 273(3): 459-466.
|
8. |
Salaun E, Clavel MA, Rodés-Cabau J, et al. Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation. Heart, 2018, 104(16): 1323-1332.
|
9. |
Soares JS, Feaver KR, Zhang W, et al. Biomechanical behavior of bioprosthetic heart valve heterograft tissues: Characterization, simulation, and performance. Cardiovasc Eng Technol, 2016, 7(4): 309-51.
|
10. |
杨晧然, 熊恬园, 陈茂. Evolut Low Risk 研究两年随访结果解读. 中国胸心血管外科临床杂志, 2021, 28(8): 884-887.
|
11. |
Sø ndergaard L, Ihlemann N, Capodanno D, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol, 2019, 73(5): 546-553.
|
12. |
Pibarot P, Ternacle J, Jaber WA, et al. Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the partner-2 trial. J Am Coll Cardiol, 2020, 76(16): 1830-43.
|
13. |
Bagur R, Pibarot P, Otto CM. Importance of the valve durability-life expectancy ratio in selection of a prosthetic aortic valve. Heart, 2017, 103(22): 1756-1759.
|
14. |
Johnson EL, Wu MCH, Xu F, et al. Thinner biological tissues induce leaflet flutter in aortic heart valve replacements. Proc Natl Acad Sci USA, 2020, 117(32): 19007-19016.
|
15. |
Martin C, Sun W. Comparison of transcatheter aortic valve and surgical bioprosthetic valve durability: A fatigue simulation study. J Biomech, 2015, 48(12): 3026-34.
|
16. |
Alavi SH, Groves EM, Kheradvar A. The effects of transcatheter valve crimping on pericardial leaflets. Ann Thorac Surg, 2014, 97(4): 1260-1266.
|
17. |
Martin C, Sun W. Transcatheter valve underexpansion limits leaflet durability: Implications for valve-in-valve procedures. Ann Biomed Eng, 2017, 45(2): 394-404.
|
18. |
Khan A, Aslam A, Satti KN, et al. Infective endocarditis post-transcatheter aortic valve implantation (TAVI), microbiological profile and clinical outcomes: A systematic review. PLoS One, 2020, 15(1): e0225077.
|
19. |
Regueiro A, Linke A, Latib A, et al. Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death. JAMA, 2016, 316(10): 1083-1092.
|
20. |
Harding D, Cahill TJ, Redwood SR, et al. Infective endocarditis complicating transcatheter aortic valve implantation. Heart, 2020, 106(7): 493-498.
|
21. |
Monteagudo Ruiz JM, Zamorano Gómez JL. Endocarditis after transcatheter aortic valve implantation: A new fiend we hardly know. Eur Heart J, 2019, 40(39): 3270-3272.
|
22. |
Wise J, 冯羽. 经导管主动脉瓣置换术后发生感染性心内膜炎的危险因素已被确认. 中华外科杂志, 2018, 56(6): 446.
|
23. |
Regueiro A, Linke A, Latib A, et al. Infective endocarditis following transcatheter aortic valve replacement: Comparison of balloon- versus self-expandable valves. Circ Cardiovasc Interv, 2019, 12(11): e007938.
|
24. |
Raad II, Hanna HA, Boktour M, et al. Catheter-related vancomycin-resistant enterococcus faecium bacteremia: Clinical and molecular epidemiology. Infect Control Hosp Epidemiol, 2005, 26(7): 658-661.
|
25. |
Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med, 2017, 376(14): 1321-1331.
|
26. |
Thourani VH, Suri R M, Gunter RL, et al. Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients. Ann Thorac Surg, 2015, 99(1): 55-61.
|
27. |
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med, 2019, 380(18): 1695-1705.
|
28. |
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med, 2019, 380(18): 1706-1715.
|
29. |
Contorni F, Fineschi M, Iadanza A, et al. How to deal with low-flow low-gradient aortic stenosis and reduced left ventricle ejection fraction: From literature review to tips for clinical practice. Heart Fail Rev, 2021. [Epub ahead of print].
|
30. |
Pasala TKR, Ruiz CE. Transcatheter aortic valve replacement for all-comers with severe aortic stenosis: Could it become a reality? Rev Esp Cardiol (Engl Ed), 2018, 71(3): 141-145.
|
31. |
Makkar RR, Blanke P, Leipsic J, et al. Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: Partner 3 cardiac computed tomography substudy. J Am Coll Cardiol, 2020, 75(24): 3003-3015.
|
32. |
Yerasi C, Rogers T, Forrestal BJ, et al. Transcatheter versus surgical aortic valve replacement in young, low-risk patients with severe aortic stenosis. JACC Cardiovasc Interv, 2021, 14(11): 1169-1180.
|
33. |
Landes U, Webb JG, De Backer O, et al. Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. J Am Coll Cardiol, 2020, 75(16): 1882-1893.
|
34. |
徐东辉, 罗新锦, 张晶, 等. 经导管主动脉瓣置换术在高龄主动脉瓣狭窄患者中的应用. 中华老年多器官疾病杂志, 2021, 20(6): 430-433.
|
35. |
Thourani VH, Edelman JJ, Satler LF, et al. Surgical aortic valve replacement in the transcatheter aortic valve replacement era: Implications for the heart team. JACC Cardiovasc Interv, 2018, 11(21): 2157-2159.
|
36. |
Tokoro M, Sawaki S, Ozeki T, et al. Totally endoscopic aortic valve replacement via an anterolateral approach using a standard prosthesis. Interact Cardiovasc Thorac Surg, 2020, 30(3): 424-430.
|
37. |
Chang C, Raza S, Altarabsheh SE, et al. Minimally invasive approaches to surgical aortic valve replacement: A meta-analysis. Ann Thorac Surg, 2018, 106(6): 1881-1889.
|
38. |
Guo MH, Boodhwani M. Aortic valve repair: From concept to future targets. Semin Thorac Cardiovasc Surg, 2019, 31(4): 650-655.
|
39. |
Tabata M. Transapical approach in transcatheter cardiovascular interventions. Gen Thorac Cardiovasc Surg, 2018, 66(4): 185-191.
|